Concepedia
Statistics
Publications
15
Citations
1.8K
H-Index
13
Active since
2004
Affiliations
GlaxoSmithKline (France)(Current)
GlaxoSmithKline (United Kingdom)
Servier (France)
GlaxoSmithKline (United States)
Institut des Hautes Études Scientifiques
Françoise Gellibert is an author at GlaxoSmithKline (France) specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyDrug DiscoveryBiochemistryFibrosisPharmacotherapyMedicinal ChemistryEngineeringInflammationDeep Learning
Publications per year
2004–2022
Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains
Chun‐wa Chung, Hervé Coste, Julia H. White et al. · Journal of Medicinal Chemistry · 2011 · 334 citations · Full text
Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-β Type I Receptor Inhibitors
Françoise Gellibert, James M. Woolven, Marie-Hélène Fouchet et al. · Journal of Medicinal Chemistry · 2004 · 217 citations · Full text
Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
Maj Petersen, Midory Thorikay, Martijn Deckers et al. · Kidney International · 2007 · 213 citations · Full text
Inflammation, Fibrosis, Urology +11
Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)
Jonathan T. Seal, Yann Lamotte, Frédéric Donche et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 207 citations · Full text
Novel Series, Medicine, Chemical Biology +4
Inhibition of TGF‐<i>β</i> signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine‐induced liver fibrosis
Anne‐Charlotte de Gouville, Valérie Boullay, Gaël Krysa et al. · British Journal of Pharmacology · 2005 · 164 citations · Full text
Liver Fibrosis, Human Growth, Pathology +18
1–5 of 15